
European Journal of Medicinal Chemistry p. 241 - 251 (1997)
Update date:2022-08-03
Topics:
Campiani
Nacci
Fiorini
De Filippis, Mp
Garofalo
Ciani
Greco
Novellino
Manzoni
Mennini
A number of new pyrrolobenzothiazepine derivatives and a pyrrolobenzothiazocine derivative have been synthesized and evaluated for their affinity towards the 'peripheral-type' benzodiazepine receptor (PBR). The new compounds were tested in rat cortex, a tissue expressing a high density of mitochondrial PBR. Some of the pyrrolobenzothiazepines exhibited IC50 values in the low nanomolar range as measured by the displacement of [3H]PK 11195 binding. Compound 4i was found to be the most potent ligand for this receptor in the pyrrolobenzothiazepine subgroup with an IC50 practically identical to that determined for PK 11195. Structure-affinity relationships (SARs) have been developed to elucidate the topology of the PBR binding site.
View MoreContact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
website:http://www.chinacharm.cn/
Contact:86 551 5316260
Address:No. 211,XiangZhang Road,Hefei City,Anhui Province,China
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Shanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Wuhan Kemi-Works Chemical Co., Ltd
website:http://www.kemiworks.com
Contact:86-27-85736489
Address:Rm. 1503, No. 164, Jianghan North Rd., Wuhan, 430022 China
Doi:10.1016/j.tetlet.2017.04.073
(2017)Doi:10.1021/jo034795e
(2003)Doi:10.1139/v67-351
(1967)Doi:10.1055/s-1997-800
(1997)Doi:10.1039/P19830001689
(1983)Doi:10.1021/om9703494
(1997)